Cite

HARVARD Citation

    Berger, Y. et al. (n.d.). Consider Routine Administration of Neoadjuvant Treatment for Resectable Pancreatic Ductal Adenocarcinoma – A Single Center Experience. HPB. pp. S314-. [Online]. 
  
Back to record